, a bio/informatics shared resource is still "open for business" - Visit the CDS website

  1. 4-hydroxynonenal induces apoptosis via caspase-3 activation and cytochrome c release. Ji C, Amarnath V, Pietenpol JA, Marnett LJ (2001) Chem Res Toxicol 14(8): 1090-6
    › Primary publication · 11511183 (PubMed)
  2. p53 regulation of G(2) checkpoint is retinoblastoma protein dependent. Flatt PM, Tang LJ, Scatena CD, Szak ST, Pietenpol JA (2000) Mol Cell Biol 20(12): 4210-23
    › Primary publication · 10825186 (PubMed) · PMC85790 (PubMed Central)
  3. p53-dependent expression of PIG3 during proliferation, genotoxic stress, and reversible growth arrest. Flatt PM, Polyak K, Tang LJ, Scatena CD, Westfall MD, Rubinstein LA, Yu J, Kinzler KW, Vogelstein B, Hill DE, Pietenpol JA (2000) Cancer Lett 156(1): 63-72
    › Primary publication · 10840161 (PubMed)
  4. Mechanisms of cell-cycle checkpoints: at the crossroads of carcinogenesis and drug discovery. Flatt PM, Pietenpol JA (2000) Drug Metab Rev 32(3-4): 283-305
    › Primary publication · 11139130 (PubMed)
  5. Treatment with farnesyl-protein transferase inhibitor induces regression of mammary tumors in transforming growth factor (TGF) alpha and TGF alpha/neu transgenic mice by inhibition of mitogenic activity and induction of apoptosis. Nørgaard P, Law B, Joseph H, Page DL, Shyr Y, Mays D, Pietenpol JA, Kohl NE, Oliff A, Coffey RJ, Poulsen HS, Moses HL (1999) Clin Cancer Res 5(1): 35-42
    › Primary publication · 9918200 (PubMed)
  6. p21(Waf1/Cip1) inhibition of cyclin E/Cdk2 activity prevents endoreduplication after mitotic spindle disruption. Stewart ZA, Leach SD, Pietenpol JA (1999) Mol Cell Biol 19(1): 205-15
    › Primary publication · 9858545 (PubMed) · PMC83879 (PubMed Central)
  7. High affinity insertion/deletion lesion binding by p53. Evidence for a role of the p53 central domain. Szak ST, Pietenpol JA (1999) J Biol Chem 274(6): 3904-9
    › Primary publication · 9920946 (PubMed)
  8. Defective G1-S cell cycle checkpoint function sensitizes cells to microtubule inhibitor-induced apoptosis. Stewart ZA, Mays D, Pietenpol JA (1999) Cancer Res 59(15): 3831-7
    › Primary publication · 10447002 (PubMed)
  9. The role of transforming growth factor beta in glioma progression. Jennings MT, Pietenpol JA (1998) J Neurooncol 36(2): 123-40
    › Primary publication · 9525812 (PubMed)
  10. Negative regulation of Wee1 expression and Cdc2 phosphorylation during p53-mediated growth arrest and apoptosis. Leach SD, Scatena CD, Keefer CJ, Goodman HA, Song SY, Yang L, Pietenpol JA (1998) Cancer Res 58(15): 3231-6
    › Primary publication · 9699647 (PubMed)